Lataa...
Add-on therapy with montelukast or formoterol in patients with the glycine-16 β(2)-receptor genotype
AIMS: We assessed whether montelukast or formoterol provides additive effects to asthmatics not controlled on inhaled corticosteroids, by studying patients who were considered to be genetically susceptible to β(2)-receptor down regulation and subsensitivity, and who expressed the homozygous glycine-...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Blackwell Science Inc
2003
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1884336/ https://ncbi.nlm.nih.gov/pubmed/12848782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.2003.01899.x |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|